Cancer Therapeutics

About Repertoire Immune Medicines

Repertoire Immune Medicines is a Flagship Pioneering-founded biotech leveraging its proprietary DECODE platform to map the immune synapse and discover the specific codes governing T cell-antigen interactions. This platform underpins a pipeline of programmable immune medicines aimed at treating cancer by eliminating tumors and autoimmune diseases by restoring immune tolerance. The company is clinical-stage, has established a significant collaboration with Eli Lilly, and is led by a seasoned team with deep expertise in immunology and drug development.

Therapeutic Areas